IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
IB Acquisition net income
Net income is the profit left for shareholders after every expense, interest and tax.
IB Acquisition's net income for the twelve months ending Jun 30, 2026 was -$399.57K, down 111.1% year over year. For fiscal 2025 it was $3.42M, up 82.9% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.42M | +82.9% |
| FY2024 | Sep 30, 2024 | $1.87M | – |
| FY2023 | Sep 30, 2023 | -$6.84K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Jun 30, 2026 | -$567.17K | -169.3% |
| Q2 FY2026 | Mar 31, 2026 | -$639.87K | -177.6% |
| Q1 FY2026 | Dec 31, 2025 | -$58.90K | -106.5% |
| Q4 FY2025 | Sep 30, 2025 | $866.37K | -16.4% |
| Q3 FY2025 | Jun 30, 2025 | $818.61K | -26.5% |
| Q2 FY2025 | Mar 31, 2025 | $824.13K | – |
| Q1 FY2025 | Dec 31, 2024 | $907.07K | – |
| Q4 FY2024 | Sep 30, 2024 | $1.04M | – |
| Q3 FY2024 | Jun 30, 2024 | $1.11M | – |
| Q2 FY2024 | Mar 31, 2024 | -$194.65K | – |
| Q1 FY2024 | Dec 31, 2023 | -$87.49K | – |
| Q4 FY2023 | Sep 30, 2023 | -$6.70K | – |
| Q3 FY2023 | Jun 30, 2023 | -$48 | – |
| Q2 FY2023 | Mar 31, 2023 | -$48 | – |
| Q1 FY2023 | Dec 31, 2022 | -$48 | – |